갑상선 암, 갑상선 결절, 갑상선 기능 이상 질환 및 내분비대사 분야의 다양한 질환의 진단 및 치료를 담당하고 있습니다. 지난 30년간 서울시립보라매병원 및 서울아산병원에서의 다양한 경험과 축적된 지식을 바탕으로 환자 한 분 한 분을 가족처럼 여기고 성심껏 진료하여 지역사회 주민의 건강한 삶 유지에 기여하도록 하겠습니다.
[논 문] Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma. [Thyroid 2024] Undercover active surveillance of small highly suspicious thyroid nodules without fine needle aspiration. [Endocrine 2024] Contralateral Low-to-Intermediate Suspicion Nodule Is Not a Contraindication for Lobectomy in Patients with Papillary Thyroid Carcinoma. [Thyroid 2023] Changes in peripheral blood immune cell population in thyroid cancer patients treated with lenvatinib. [Scientific Reports 2023] Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib. [Endocrine 2023] Serum thyroglobulin testing after thyroid lobectomy in patients with 1-4 cm papillary thyroid carcinoma. [Endocrine 2023] Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort. [European Thyroid Journal 2023] Limitations of fine-needle aspiration and core needle biopsies in the diagnosis of tall cell variant of papillary thyroid carcinoma. [Clinical Endocrinology 2023] Prognosis of Patients with 1-4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles. [Annals of Surgical Oncology 2022] Effects of dabrafenib and erlotinib combination treatment on anaplastic thyroid carcinoma. [Endocrine Related Cancer 2022] Clinical implications of age and excellent response to therapy in patients with high-risk differentiated thyroid carcinoma. [Clinical Endocrinology 2021] Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea. [Thyroid 2021] [학술상] 대한내분비학회 오가논학술상 2008년도 대한내과학회 연구상 대한내분비학회 남곡학술상 The Nakataki-Fujifilm Prize (AOTA)